LEONARDI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 7.014
AS - Asia 1.023
EU - Europa 958
SA - Sud America 48
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 9.062
Nazione #
US - Stati Uniti d'America 7.002
SG - Singapore 577
CN - Cina 318
IT - Italia 232
DE - Germania 164
FI - Finlandia 155
HK - Hong Kong 86
UA - Ucraina 79
GB - Regno Unito 73
RU - Federazione Russa 72
FR - Francia 70
SE - Svezia 57
BR - Brasile 43
NL - Olanda 20
VN - Vietnam 16
IE - Irlanda 9
IN - India 8
AT - Austria 6
CA - Canada 6
MX - Messico 5
PL - Polonia 5
CI - Costa d'Avorio 4
EU - Europa 4
BE - Belgio 3
ID - Indonesia 3
LT - Lituania 3
PK - Pakistan 3
AU - Australia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
GH - Ghana 2
HU - Ungheria 2
NP - Nepal 2
TR - Turchia 2
VE - Venezuela 2
AR - Argentina 1
AZ - Azerbaigian 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EC - Ecuador 1
HN - Honduras 1
IR - Iran 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
OM - Oman 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 9.062
Città #
Fairfield 1.119
Woodbridge 702
Houston 529
Chandler 502
Ashburn 442
Ann Arbor 408
Jacksonville 401
Cambridge 399
Seattle 391
Wilmington 380
Santa Clara 310
Singapore 284
Boardman 183
Princeton 182
San Diego 116
Roxbury 91
Hong Kong 85
Padova 74
Beijing 73
Medford 72
Helsinki 64
Des Moines 58
Nanjing 58
Nanchang 22
New York 21
Treviso 18
Dong Ket 16
Shenyang 16
Hebei 15
Villafranca Padovana 15
Guangzhou 14
London 14
Tianjin 14
Milan 12
Nuremberg 12
Dallas 11
Jiaxing 11
Jinan 11
Dublin 9
Grafing 9
Redwood City 8
Codognè 7
Kilburn 7
Lappeenranta 7
Los Angeles 7
Ogden 7
Zhengzhou 7
Norwalk 6
Changsha 5
Falls Church 5
Hounslow 5
Rome 5
Shanghai 5
Tappahannock 5
The Dalles 5
Verona 5
Abidjan 4
Chicago 4
Munich 4
Naples 4
Nürnberg 4
Pune 4
Vicenza 4
Brunssum 3
Frankfurt am Main 3
Haikou 3
Kharkiv 3
Lodz 3
Ningbo 3
Palembang 3
Palermo 3
San Francisco 3
Acton 2
Alghero 2
Algiers 2
Amsterdam 2
Bari 2
Beauharnois 2
Brussels 2
Campolongo Maggiore 2
Coral Gables 2
Council Bluffs 2
Falkenstein 2
Farra di Soligo 2
Fontanelle 2
Fuzhou 2
Goiânia 2
Grassobbio 2
Hangzhou 2
Hermosillo 2
Indiana 2
Kathmandu 2
Klaipėda 2
Kumasi 2
Kunming 2
Lanzhou 2
Las Vegas 2
Magé 2
Olomouc 2
Porto Alegre 2
Totale 7.370
Nome #
Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma 156
Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type, and are modified by inflammatory stimuli 150
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression 134
Tear histamine and histaminase during the early (EPR) and late (LPR) phases of the allergic reaction and the effects of Lodoxamide. 128
A novel plasma source for sterilization of living tissues 127
Efficacy and Tolerability of Ketotifen in the Treatment Of Seasonal Allergic Conjunctivitis: Comparison between Ketotifen 0.025% and 0.05% Eye Drops 124
Vernal keratoconjunctivitis-like disease in adults 122
Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis 119
Urokinase Plasminogen Activator, uPa Receptor, and Its Inhibitor in Vernal Keratoconjunctivitis 117
A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study 117
Corneal staining patterns in vernal keratoconjunctivitis: The new VKC-CLEK scoring scale 117
Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis. 116
Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy 116
Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities 115
Urban eye allergy syndrome: a new clinical entity? 114
Unusual high exposure to ultraviolet-C radiation 114
Th1- and Th2-type cytokines in chronic ocular allergy 113
Microarray-based IgE detection in tears of patients with vernal keratoconjunctivitis 112
Using helium-generated cold plasma to control infection and healing 109
Profile of Lipid and Protein Autacoids in Diabetic Vitreous Correlates With the Progression of Diabetic Retinopathy 108
Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans 107
Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. 107
Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis 106
Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. 104
Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis. 103
Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma 101
Characterisation of the phenotype and function of monocyte-derived dendritic cells in allergic conjunctiva 100
Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. 98
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: A pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies 98
Managing ocular allergy in the time of COVID-19 98
Atmospheric-pressure cold plasma induces transcriptional changes in ex vivo human corneas 97
Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis 95
Is visual function affected in severe ocular allergies? 94
Tailored Approach to the Treatment of Vernal Keratoconjunctivitis 93
Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population. 93
Emerging drugs for ocular allergy 92
Olopatadine: a drug for allergic conjunctivitis targeting the mast cell 91
The regulatory activity of autophagy in conjunctival fibroblasts and its possible role in vernal keratoconjunctivitis 90
Effect of ofloxacin and netilmicin on human corneal and conjunctival cells in vitro 89
Allergic conjunctivitis: A cross-sectional study 89
Tear eosinophil cationic protein (ECP) in tears of normal subjects and patients affected by vernal keratoconjunctivitis. 88
Histaminase activity in vernal keratoconjunctivitis. 87
Prevalence of vernal keratoconjunctivitis: a rare disease? 87
Allergy and allergic mediators in tears 87
Cytokines, growth factors and MMPs in tears of vernal keratoconjunctivitis (VKC) patients 87
Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis. 86
Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model 84
Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. 82
Effects of cyclosporin A on human conjunctival fibroblasts 82
Detection of severe acute respiratory syndrome coronavirus 2 in corneas from asymptomatic donors 82
Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis 80
Corneal confocal microscopy in patients with vernal keratoconjunctivitis 80
Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases 80
Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. 79
Vernal keratoconjunctivitis: pathogenesis and treatment 77
Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis 77
Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score 76
Effects of Th2 cytochines on expression of collagen, MMP-1 and TIMP-1 in conjunctival fibroblasts 75
Conjunctival allergen provocation test : guidelines for daily practice 75
Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. 74
Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. 74
Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments 74
Ocular Surface Expression of SARS-CoV-2 Receptors 73
Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease 72
Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in keratoconjunctivitis patients 71
Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics 71
Office-based ocular procedures for the allergist 70
Towards a plasma treatment of corneal infections 69
Vernal keratoconjunctivitis: A severe allergic eye disease with remodeling changes 69
Cytokine and chemochine levels in tears and in corneal fibroblast cultures before and after excimer laser treatment 68
Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis 68
Small fiber peripheral neuropathy in Wilson disease: an in vivo documentation by corneal confocal microscopy. 67
Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study 64
Epidemiology of allergic conjunctivitis: Clinical appearance and treatment patterns in a population-based study 64
Efficacy and comfort of olopatadine vs ketotifen ophthalmic solutions 61
In-vivo diagnostic measurements of ocular inflammation 61
Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine 57
Nonsteroidal antiinflammatory drugs after excimer laser photorefractive keratectomy (PRK): A randomized double blind study 55
Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis 55
Allergy and the eye 54
Ocular Surface Expression of SARS-CoV-2 Receptors 54
In vitro effects of fluorochinolone and aminoglycoside antibiotics on human keratocytes 53
Investigation of the effects of atmospheric pressure cold plasma 52
Heat shock proteins levels and expression in chronic obstructive pulmonary disease and vernal keratoconjunctivitis 52
Trypsin inhibitory capacity in vernal keratoconjunctivitis 52
Clinical patterns of ocular anaphylaxis in guinea pigs passively sensitized with IgG1 antibodies. 52
Growth factors and collagen distribution in vernal keratoconjunctivitis 51
Allergy and Dry Eye Disease 50
Characterization of dendritic cell phenotype in allergic conjunctiva: increased expression of Fc epsilon RI, the high-affinity receptor for immunoglobulin E 49
Eosinophils and CD4+ cells contribute to MMP production and tissue remodeling in veronal keratoconjunctivitis and other allergic diseases 48
Differential expression of matrix metalloproteinases in vernal keratoconjunctivitis, allergic asthma and nasal polyps 46
Low temperature plasma device for the treatment of corneal infections 46
Effects of cold plasma on pathogenic microorganisms, cells and corneal tissues. 46
Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19 46
Metagenomic analysis of the conjunctival bacterial and fungal microbiome in vernal keratoconjunctivitis 45
Two years specific sublingual immunotherapy with alternaria extracts 44
Allergic conjunctivitis: a cross-sectional study 44
Management of ocular allergy 44
Management of Vernal Keratoconjunctivitis 42
Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. 42
Totale 8.273
Categoria #
all - tutte 39.452
article - articoli 38.322
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 156
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020311 0 0 0 0 0 0 0 0 0 156 89 66
2020/20211.426 54 74 29 105 46 113 206 152 257 154 157 79
2021/20221.517 35 165 187 88 73 64 116 160 93 29 162 345
2022/20231.007 250 89 60 100 169 96 1 65 104 9 49 15
2023/2024479 19 73 53 43 23 36 16 18 45 10 73 70
2024/20251.676 10 241 139 86 437 63 161 243 223 73 0 0
Totale 9.221